Integris Cancer Institute of Oklahoma — Oklahoma City, Oklahoma

Integris Cancer Institute of Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73142.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Integris Cancer Institute of Oklahoma has participated in 35 clinical trials with 23 currently active.

Therapeutic areas: Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Integris Cancer Institute of Oklahoma?

Integris Cancer Institute of Oklahoma has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Integris Cancer Institute of Oklahoma conducted?

Integris Cancer Institute of Oklahoma has 35 clinical trials on record, with 23 currently active. Their work covers Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma.

Is Integris Cancer Institute of Oklahoma accredited by Crixeo Health?

Yes — Integris Cancer Institute of Oklahoma holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Integris Cancer Institute of Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.